within Pharmacolibrary.Drugs.C_CardiovascularSystem.C02K_OtherAntihypertensives.C02KA01_Veratrum;

model Veratrum
  extends Pharmacolibrary.Drugs.ATC.C.C02KA01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C02KA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Veratrum is an alkaloid-containing plant derivative historically used as an antihypertensive agent, but due to toxicity and significant side effects, it is rarely or no longer used in modern clinical practice. Its main mechanism of action is as a ganglionic blocker and it also possesses emetic properties.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult humans as no direct published pharmacokinetic models or detailed clinical pharmacokinetic studies are available for veratrum alkaloids. Parameters are estimated based on expected PK behavior of structurally and pharmacologically similar alkaloids.</p><h4>References</h4><ol><li><p>Fan, Y, et al., &amp; He, J (2020). UPLC-MS/MS Method for the Simultaneous Quantification of Eight Compounds in Rat Plasma and Its Application to a Pharmacokinetic Study after Oral Administration of Veratrum (. <i>BioMed research international</i> 2020 8883277–None. DOI:<a href=&quot;https://doi.org/10.1155/2020/8883277&quot;>10.1155/2020/8883277</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33134392/&quot;>https://pubmed.ncbi.nlm.nih.gov/33134392</a></p></li><li><p>Cong, Y, et al., &amp; Cai, Z (2016). Pharmacokinetics and metabolism study of veratramine in mice after oral administration using LC-MS/MS. <i>Biomedical chromatography : BMC</i> 30(9) 1515–1522. DOI:<a href=&quot;https://doi.org/10.1002/bmc.3717&quot;>10.1002/bmc.3717</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26972867/&quot;>https://pubmed.ncbi.nlm.nih.gov/26972867</a></p></li><li><p>Zheng, B, et al., &amp; Xiang, Z (2019). Pharmacokinetics and enterohepatic circulation of jervine, an antitumor steroidal alkaloid from . <i>Journal of pharmaceutical analysis</i> 9(5) 367–372. DOI:<a href=&quot;https://doi.org/10.1016/j.jpha.2019.04.004&quot;>10.1016/j.jpha.2019.04.004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31929946/&quot;>https://pubmed.ncbi.nlm.nih.gov/31929946</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Veratrum;
